1. Home
  2. AAPG vs VTMX Comparison

AAPG vs VTMX Comparison

Compare AAPG & VTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • VTMX
  • Stock Information
  • Founded
  • AAPG 2009
  • VTMX 1998
  • Country
  • AAPG China
  • VTMX Mexico
  • Employees
  • AAPG N/A
  • VTMX N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • VTMX
  • Sector
  • AAPG Health Care
  • VTMX
  • Exchange
  • AAPG Nasdaq
  • VTMX Nasdaq
  • Market Cap
  • AAPG 2.2B
  • VTMX 2.3B
  • IPO Year
  • AAPG 2025
  • VTMX 2023
  • Fundamental
  • Price
  • AAPG $24.40
  • VTMX $28.84
  • Analyst Decision
  • AAPG Buy
  • VTMX Sell
  • Analyst Count
  • AAPG 1
  • VTMX 2
  • Target Price
  • AAPG N/A
  • VTMX $27.50
  • AVG Volume (30 Days)
  • AAPG 14.1K
  • VTMX 263.0K
  • Earning Date
  • AAPG 06-10-2025
  • VTMX 07-24-2025
  • Dividend Yield
  • AAPG N/A
  • VTMX 2.46%
  • EPS Growth
  • AAPG N/A
  • VTMX N/A
  • EPS
  • AAPG N/A
  • VTMX 0.13
  • Revenue
  • AAPG $134,352,180.00
  • VTMX $258,927,122.00
  • Revenue This Year
  • AAPG N/A
  • VTMX $17.35
  • Revenue Next Year
  • AAPG $389.09
  • VTMX $11.82
  • P/E Ratio
  • AAPG N/A
  • VTMX $20.83
  • Revenue Growth
  • AAPG 341.77
  • VTMX 15.06
  • 52 Week Low
  • AAPG $16.50
  • VTMX $21.30
  • 52 Week High
  • AAPG $26.55
  • VTMX $34.88
  • Technical
  • Relative Strength Index (RSI)
  • AAPG N/A
  • VTMX 62.73
  • Support Level
  • AAPG N/A
  • VTMX $28.96
  • Resistance Level
  • AAPG N/A
  • VTMX $29.60
  • Average True Range (ATR)
  • AAPG 0.00
  • VTMX 0.73
  • MACD
  • AAPG 0.00
  • VTMX -0.12
  • Stochastic Oscillator
  • AAPG 0.00
  • VTMX 56.05

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

Share on Social Networks: